The global interventional oncology market size is poised to grow by USD 781.89 million during 2020-2024, progressing at a CAGR of almost 7% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201028005953/en/
Technavio has announced its latest market research report titled Global Interventional Oncology Market 2020-2024 (Graphic: Business Wire)
The increasing cancer population is expected to drive the market growth. Cancer is one of the leading causes of death worldwide. Lung, liver, stomach, colorectal, breast, and esophageal cancers are prevalent among the population worldwide. Changes in lifestyle, unhealthy diet, smoking, fewer pregnancies, and longtime UV exposure are expected to increase the prevalence of cancers, such as breast cancer, lung cancer, and colorectal cancer, associated with these factors. The majority of cancers at chronic stages cannot be treated with conventional drugs. This is expected to increase the demand for interventional oncology procedures, such as tissue ablation and embolization, thereby driving the market growth.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Report Highlights:
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Growing Demand for Minimally-Invasive Surgical Procedures will be a Key Market Trend
Globally, surgeons and patients are increasingly opting for minimally-invasive surgeries. Minimally-invasive techniques are used to treat patients with other associated comorbidities and in inoperable patients. Also, these minimally-invasive and non-invasive techniques are increasingly used to manage diseases, such as cancerous tumors, and most commonly in treating solid selected tumors, which include tumors in the kidneys, lungs, and the liver. Interventional oncology procedure uses HIFU beam light, microsphere, delivery of electricity, and microspheres filled with radioisotopes to destroy or kill the affected tumors cells. Minimally-invasive surgeries reduce the risk of infection, cause minimal complications, lead to a shorter hospital stay, cause less pain, and have a faster recovery time compared to traditional open surgeries.
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Interventional Oncology Market 2020-2024: Key Highlights
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Procedure
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201028005953/en/
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/